Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation

Low-Dose Valproic Acid Enhances Radiosensitivity of Prostate Cancer through Acetylated p53-Dependent Modulation of Mitochondrial Membrane Potential and Apoptosis

(2011) X. Chen et al.   MOLECULAR CANCER RESEARCH

Enhanced Radiosensitivity of Androgen-Resistant Prostate Cancer: AZD1152-Mediated Aurora Kinase B Inhibition

(2011) Kenneth J Niermann et al.   RADIATION RESEARCH

Celecoxib Enhances Radiation Response of Secondary Bone Tumors of a Human Non-Small Cell Lung Cancer via Antiangiogenesis In Vivo

(2011) Frank Michael Klenke et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Comparison of the Micronucleus and Chromosome Aberration Techniques for the Documentationof Cytogenetic Damage in Radiochemotherapy-Treated Patients with Rectal Cancer

(2011) Hendrik Andreas Wolff* et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Enhancement of Radiation Response in Osteosarcoma and Rhabomyosarcoma Cell Lines by Histone Deacetylase Inhibition

(2010) Claudia Blattmann et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Second Malignancies in High‑Dose Areas of Previous Tumor Radiotherapy

(2010) Birgitta Welte et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis

(2009) Y.-L. Chung et al.   CARCINOGENESIS

Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts

(2009) A. Baschnagel et al.   MOLECULAR CANCER THERAPEUTICS

Additive Effects of 5-Aza-2’-deoxycytidine and Irradiation on Clonogenic Survival of Human Medulloblastoma Cell Lines

(2009) Ina Patties et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Second Malignant Neoplasms After Childhood Cancer in Germany – Results from the Long-term Follow-up of the German Childhood Cancer Registry

(2009) Peter Kaatsch et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Histone deacetylase inhibitors in cancer therapy

(2008) Min-Jung Lee et al.   CURRENT OPINION IN ONCOLOGY

Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest

(2008) A. A. Levesque et al.   MOLECULAR CANCER THERAPEUTICS